3 results ยท Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
PROACTIVE-HF-2 Trial Heart Failure NYHA Class II and IIIcardiovascular disorder, heart disorder, heart failureRecruitingNot applicable2026-06-29NCT05934487
Cyclosporine Vs Steroids in DRESSChemically-Induced Disorders, Drug Eruptions, Drug-Related Side Effects and Adverse Reactions, Hypersensitivity, Delayed, Skin and Connective Tissue Diseases, dermatitis, drug allergy, drug rash with eosinophilia and systemic symptoms, immune system disorder, skin disorderEnrolling by invitationEarly phase 12025-03-30NCT04988256
This is a Study to Evaluate the Safety and Tolerability of ABL503, and to Determine the Maximum Tolerated Dose (MTD) and Recommended Phase 2 Dose (RP2D) of ABL503 in Subjects with Any Progressive Locally Advanced or Metastatic Solid TumorsAdvanced Solid TumorRecruitingPhase 12025-02-06NCT04762641